Pricing Log in Create free account

Silence Therapeutics PLC Sponsored ADR (SLN) vs Shattuck Labs, Inc. (STTK)

Silence Therapeutics PLC Sponsored ADR and Shattuck Labs, Inc. are both Biotechnology companies. Silence Therapeutics PLC Sponsored ADR and Shattuck Labs, Inc. are of similar size ($581.1M and $555.0M). Shattuck Labs, Inc. grew revenue faster over the last twelve months: 106.5% against −97.0%. Across the 14 metrics below, Shattuck Labs, Inc. leads on 12 and Silence Therapeutics PLC Sponsored ADR on 2.

Valuation

Metric SLN STTK Biotechnology median
P/E n/m n/m 8.50
P/S 488.70 125.47 9.71
P/B 10.66 3.33 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 402.90 88.32 9.21
Earnings yield (14.75%) (9.41%) (33.15%)
Free cash flow yield (10.32%) (5.86%) (25.50%)

Profitability

Metric SLN STTK Biotechnology median
Gross margin 79.50% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (90.41%) (39.21%) (56.36%)
Return on assets (44.14%) (36.88%) (48.04%)
Return on invested capital 0.00% (1,230.74%) 0.00%

Growth

Metric SLN STTK Biotechnology median
Revenue growth (TTM) (96.97%) 106.48% 6.02%
EPS growth (last fiscal year) (90.91%) 53.02% 30.26%
Revenue growth, 5-year CAGR (39.74%) (36.82%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SLN STTK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.42 27.59 4.72
Net debt to EBITDA 0.94 1.62 0.96

Dividend

Metric SLN STTK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SLN STTK Biotechnology median
Market cap 581.10m 555.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack